Gene · 134
Papers2,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine. | J Clin Endocrinol Metab | 2021 | 34000025 | PubTator, text mining | PubMed |
| How Genetics Might Explain the Unusual Link Between Malaria and COVID-19. | Front Med (Lausanne) | 2021 | 33981715 | PubTator, text mining | PubMed |
| Genetic variation affects morphological retinal phenotypes extracted from UK Biobank optical coherence tomography images. | PLoS Genet | 2021 | 33979322 | PubTator, text mining | PubMed |
| ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling. | Life Sci | 2021 | 33961854 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking. | Pharmacol Biochem Behav | 2021 | 33940055 | PubTator, text mining | PubMed |
| Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment? | Front Pharmacol | 2021 | 33935767 | PubTator, text mining | PubMed |
| Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches. | Molecules | 2021 | 33920326 | PubTator, text mining | PubMed |
| Design and Synthesis of 2,6-Disubstituted-4'-Selenoadenosine-5'-N,N-Dimethyluronamide Derivatives as Human A3 Adenosine Receptor Antagonists. | Pharmaceuticals (Basel) | 2021 | 33920062 | PubTator, text mining | PubMed |
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. | Cell Rep | 2021 | 33910017 | PubTator, text mining | PubMed |
| Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss. | Sci Rep | 2021 | 33854102 | PubTator, text mining | PubMed |
| An in silico approach to target RNA-dependent RNA polymerase of COVID-19 with naturally occurring phytochemicals. | Environ Dev Sustain | 2021 | 33841038 | PubTator, text mining | PubMed |
| Sex Differences in MicroRNA Expression and Cardiometabolic Risk Factors in Hispanic Adolescents with Obesity. | J Pediatr | 2021 | 33831442 | PubTator, text mining | PubMed |
| Paeoniflorin Enhances Endometrial Receptivity through Leukemia Inhibitory Factor. | Biomolecules | 2021 | 33809755 | PubTator, text mining | PubMed |
| Every Detail Matters. That Is, How the Interaction between Gα Proteins and Membrane Affects Their Function. | Membranes (Basel) | 2021 | 33804791 | PubTator, text mining | PubMed |
| CRISPR Gene-Editing Models Geared Toward Therapy for Hereditary and Developmental Neurological Disorders. | Front Pediatr | 2021 | 33791256 | PubTator, text mining | PubMed |
| Multisite Model of Allosterism for the Adenosine A1 Receptor. | J Chem Inf Model | 2021 | 33779168 | PubTator, text mining | PubMed |
| Enhancing Extracellular Adenosine Levels Restores Barrier Function in Acute Lung Injury Through Expression of Focal Adhesion Proteins. | Front Mol Biosci | 2021 | 33778007 | PubTator, text mining | PubMed |
| Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis. | Front Oncol | 2021 | 33777805 | PubTator, text mining | PubMed |
| A Genetic Risk Score Improves the Prediction of Type 2 Diabetes Mellitus in Mexican Youths but Has Lower Predictive Utility Compared With Non-Genetic Factors. | Front Endocrinol (Lausanne) | 2021 | 33776940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134/papers?page=30